Biosimilars, Contract Manufacturing, Licensed Products
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
869
NCT03349385
Registry of Secondary Revascularization
Phase: N/A
Role: Collaborator
Start: Nov 22, 2017
Completion: Dec 15, 2025
Loading map...